Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1975 May;54(1):91–100. doi: 10.1111/j.1476-5381.1975.tb07414.x

Interaction of competitive antagonists: the anti-curare action of hexamethonium and other antagonists at the skeletal neuromuscular junction.

J G Blackman, R W Gauldie, R J Milne
PMCID: PMC1666385  PMID: 166720

Abstract

1. In the rat isolated diaphragm preparation hexamethonium and other low potency competitive antagonists of acetylcholine (ACh), including gallamine and hyoscine butylbromide, reverse block by the potent antagonists tubocurarine, pancuronium and alcuronium. 2. In the presence of tubocurarine, hexamethonium increases the amplitude of the end-plate potential without increasing the quantal content. It enhances the response to ACh applied iontophoretically to the end-plate but does not enhance the response to ACh applied in the bath. 3. The anti-curare effect of hexamethonium is abolished in the diaphragm of the rat, guinea-pig and mouse by inhibitors of acetylcholinesterase. The effect is not observed in the indirectly stimulated toad sartorius muscle. 4. The effect is explained if tubocurarine does not dissociate appreciably in the time taken for ACh to achieve high occupancy of receptors, so that a fraction of receptors is completely excluded from occupation by ACh. Equilibration with hexamethonium reduces the fraction excluded by tubocurarine and the transmitter now competes with hexamethonium for more receptors and produces a larger response. 5. On the basis of this explanation the half-time for dissociation of tubocurarine must be about 1 millisecond. It follows that tubocurarine does not act competitively with ACh at synapses when transmitter action is sufficiently brief, and that its binding to the receptor is probably diffusion-limited.

Full text

PDF
91

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARIENS E. J., VAN ROSSUM J. M., SIMONIS A. M. A theoretical basis of molecular pharmacology. I. Interactions of one or two compounds with one receptor system. Arzneimittelforschung. 1956 May;6(5):282–293. [PubMed] [Google Scholar]
  2. Beránek R., Vyskocil F. The action of tubocurarine and atropine on the normal and denervated rat diaphragm. J Physiol. 1967 Jan;188(1):53–66. doi: 10.1113/jphysiol.1967.sp008123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beránek R., Vyskocil F. The effect of atropine on the frog sartorius neuromuscular junction. J Physiol. 1968 Mar;195(2):493–503. doi: 10.1113/jphysiol.1968.sp008470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bowen J. M. Estimation of the dissociation constant of d-tubocurarine and the receptor for endogenous acetylcholine. J Pharmacol Exp Ther. 1972 Nov;183(2):333–340. [PubMed] [Google Scholar]
  5. Burgen A. S. The drug-receptor complex. J Pharm Pharmacol. 1966 Mar;18(3):137–149. doi: 10.1111/j.2042-7158.1966.tb07840.x. [DOI] [PubMed] [Google Scholar]
  6. Dreyer F., Peper K., Akert K., Sandri C., Moor H. Ultrastructure of the "active zone" in the frog neuromuscular junction. Brain Res. 1973 Nov 23;62(2):373–380. doi: 10.1016/0006-8993(73)90699-9. [DOI] [PubMed] [Google Scholar]
  7. Ferry C. B., Marshall A. R. An anti-curare effect of hexamethonium at the mammalian neuromuscular junction. Br J Pharmacol. 1973 Feb;47(2):353–362. doi: 10.1111/j.1476-5381.1973.tb08333.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gage P. W., Armstrong C. M. Miniature end-plate currents in voltage-clamped muscle fibre. Nature. 1968 Apr 27;218(5139):363–365. doi: 10.1038/218363b0. [DOI] [PubMed] [Google Scholar]
  9. Gingsborg B. L., Stephenson R. P. On the simultaneous action of two competitive antagonists. Br J Pharmacol. 1974 Jun;51(2):287–300. doi: 10.1111/j.1476-5381.1974.tb09659.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hubbard J. I. Microphysiology of vertebrate neuromuscular transmission. Physiol Rev. 1973 Jul;53(3):674–723. doi: 10.1152/physrev.1973.53.3.674. [DOI] [PubMed] [Google Scholar]
  11. JENKINSON D. H. The antagonism between tubocurarine and substances which depolarize the motor end-plate. J Physiol. 1960 Jul;152:309–324. doi: 10.1113/jphysiol.1960.sp006489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Katz B., Miledi R. The binding of acetylcholine to receptors and its removal from the synaptic cleft. J Physiol. 1973 Jun;231(3):549–574. doi: 10.1113/jphysiol.1973.sp010248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Katz B., Miledi R. The effect of atropine on acetylcholine action at the neuromuscular junction. Proc R Soc Lond B Biol Sci. 1973 Nov 27;184(1075):221–226. doi: 10.1098/rspb.1973.0046. [DOI] [PubMed] [Google Scholar]
  14. Kruckenberg P., Bauer H. Die Dissoziationskonstante zwischen curare und dem Acetylcholin-Receptor. Pflugers Arch. 1971;326(2):184–192. doi: 10.1007/BF00586909. [DOI] [PubMed] [Google Scholar]
  15. Lu T. C. Affinity of curare-like compounds and their potency in blocking neuromuscular transmission. J Pharmacol Exp Ther. 1970 Sep;174(3):560–566. [PubMed] [Google Scholar]
  16. Negrette J., Del Castillo J., Escobar I., Yankelevich G. Spreading activation of end-plate receptors by single transmitter quanta. Nat New Biol. 1972 Feb 2;235(57):158–159. doi: 10.1038/newbio235158a0. [DOI] [PubMed] [Google Scholar]
  17. Paton W. D., Waud D. R. The margin of safety of neuromuscular transmission. J Physiol. 1967 Jul;191(1):59–90. doi: 10.1113/jphysiol.1967.sp008237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stephenson R. P., Ginsborg B. L. Potentiation by an antagonist. Nature. 1969 May 24;222(5195):790–791. doi: 10.1038/222790a0. [DOI] [PubMed] [Google Scholar]
  19. TRENDELENBURG U. Observations on the mode of action of some non-depolarizing ganglion-blocking substances. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1961;241:452–466. doi: 10.1007/BF00246689. [DOI] [PubMed] [Google Scholar]
  20. VAN ROSSUM J. M., ARIENS E. J. Pharmacodynamics of drugs affecting the blood pressure; structure-action relationships of quaternary ganglionic and parasympathetic drugs. Arch Int Pharmacodyn Ther. 1959 Feb 1;118(3-4):447–466. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES